An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Drug Acquiring Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to contact these profiles privately for source information, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and assertions of rapid UK delivery. Sellers market the drug there before directing customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Experts Voice Worries
Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could lead to users administering products of unknown origin.
Some experts stated the demand for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, marketing, and consumer regulations, risking penalties, legal action or prison.
Platform Reaction and Content Removal
According to TikTok, the platform has taken down problematic material and prohibited associated keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and allocating resources in strengthening compliance measures.
Online Trading Activities
Research also found communities with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step instructions for mixing or administering at home.
Within minutes of joining one community, a seller shared contact information, where most purchases occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, medical conditions or past usage.
Product Information and Costs
Within these communities, posts show black plastic parcels with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When questioned how long a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram stated it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting materials they can’t verify. Although the science behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her team has previously encountered individuals harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational product not yet authorized … may subject users to potentially serious health risks”.
